These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 16792175)

  • 1. Eosinophilic nasal polyps are a rich source of eotaxin, eotaxin-2 and eotaxin-3.
    Olze H; Förster U; Zuberbier T; Morawietz L; Luger EO
    Rhinology; 2006 Jun; 44(2):145-50. PubMed ID: 16792175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticosteroids inhibit mRNA expression for eotaxin, eotaxin-2, and monocyte-chemotactic protein-4 in human airway inflammation with eosinophilia.
    Jahnsen FL; Haye R; Gran E; Brandtzaeg P; Johansen FE
    J Immunol; 1999 Aug; 163(3):1545-51. PubMed ID: 10415058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eotaxin-1, -2, and -3 immunoreactivity and protein concentration in the nasal polyps of eosinophilic chronic rhinosinusitis patients.
    Yao T; Kojima Y; Koyanagi A; Yokoi H; Saito T; Kawano K; Furukawa M; Kusunoki T; Ikeda K
    Laryngoscope; 2009 Jun; 119(6):1053-9. PubMed ID: 19296494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of eotaxin and RANTES messenger RNA in nasal polyps: association of tissue and nasal eosinophils.
    Shin SH; Park JY; Jeon CH; Choi JK; Lee SH
    Laryngoscope; 2000 Aug; 110(8):1353-7. PubMed ID: 10942140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-4 and TNF-alpha increased the secretion of eotaxin from cultured fibroblasts of nasal polyps with eosinophil infiltration.
    Yoshifuku K; Matsune S; Ohori J; Sagara Y; Fukuiwa T; Kurono Y
    Rhinology; 2007 Sep; 45(3):235-41. PubMed ID: 17956026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical localization of eotaxin immunoreactivity in nasal polyps.
    Seto H; Suzaki H; Shioda S
    Acta Otolaryngol Suppl; 2004 Aug; (553):99-104. PubMed ID: 15277046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of chemokines in nasal polyps].
    Caversaccio M; Hartnell A; Calnan D; Jose P; Mackay IS; Uguccioni M; Baggiolini M; Williams TJ; Conroy DM
    Schweiz Med Wochenschr; 2000; Suppl 125():92S-95S. PubMed ID: 11141953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RANTES, eotaxin and eotaxin-2 expression and production in patients with aspirin triad.
    Pods R; Ross D; van Hülst S; Rudack C; Maune S
    Allergy; 2003 Nov; 58(11):1165-70. PubMed ID: 14616128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased eotaxin-mRNA expression in non-atopic and atopic nasal polyps: comparison to RANTES and MCP-3 expression.
    Bartels J; Maune S; Meyer JE; Kulke R; Schlüter C; Röwert J; Christophers E; Schröder JM
    Rhinology; 1997 Dec; 35(4):171-4. PubMed ID: 9532637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophil infiltration and activation in nasal polyposis.
    Fan GK; Wang H; Takenaka H
    Acta Otolaryngol; 2007 May; 127(5):521-6. PubMed ID: 17453479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal fluid release of eotaxin-3 and eotaxin-2 in persistent sinonasal eosinophilic inflammation.
    De Corso E; Baroni S; Battista M; Romanello M; Penitente R; Di Nardo W; Passali GC; Sergi B; Fetoni AR; Bussu F; Zuppi C; Paludetti G
    Int Forum Allergy Rhinol; 2014 Aug; 4(8):617-24. PubMed ID: 24989688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nasal polyps is not a homogenous pathology].
    Arcimowicz M; Balcerzak J; Samoliński BK
    Pol Merkur Lekarski; 2005 Sep; 19(111):276-9. PubMed ID: 16358841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial and epithelial expression of eotaxin-2 (CCL24) in nasal polyps.
    Schaefer D; Meyer JE; Pods R; Pethe W; Hedderich J; Schmidt C; Maune S
    Int Arch Allergy Immunol; 2006; 140(3):205-14. PubMed ID: 16682802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of eotaxin-3 distinguishes between eosinophilic esophagitis and gastroesophageal reflux disease.
    Bhattacharya B; Carlsten J; Sabo E; Kethu S; Meitner P; Tavares R; Jakate S; Mangray S; Aswad B; Resnick MB
    Hum Pathol; 2007 Dec; 38(12):1744-53. PubMed ID: 17900656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eotaxin-2 and eotaxin-3 expression is associated with persistent eosinophilic bronchial inflammation in patients with asthma after allergen challenge.
    Ravensberg AJ; Ricciardolo FL; van Schadewijk A; Rabe KF; Sterk PJ; Hiemstra PS; Mauad T
    J Allergy Clin Immunol; 2005 Apr; 115(4):779-85. PubMed ID: 15805998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eotaxin-3 is involved in Churg-Strauss syndrome--a serum marker closely correlating with disease activity.
    Polzer K; Karonitsch T; Neumann T; Eger G; Haberler C; Soleiman A; Hellmich B; Csernok E; Distler J; Manger B; Redlich K; Schett G; Zwerina J
    Rheumatology (Oxford); 2008 Jun; 47(6):804-8. PubMed ID: 18397958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and significance of Eotaxin and Eotaxin-2 in nasal polyposis and nasal polyp tissue].
    Deng Y; Tao Z; Chen J; Xiao B; Kong Y; Wu Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Jan; 21(2):75-8. PubMed ID: 17438849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of RANTES in nasal polyposis.
    Meyer JE; Bartels J; Görögh T; Sticherling M; Rudack C; Ross DA; Maune S
    Am J Rhinol; 2005; 19(1):15-20. PubMed ID: 15794069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media.
    Iino Y; Kakizaki K; Katano H; Saigusa H; Kanegasaki S
    Clin Exp Allergy; 2005 Oct; 35(10):1370-6. PubMed ID: 16238798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis.
    Leonardi A; Jose PJ; Zhan H; Calder VL
    Ophthalmology; 2003 Mar; 110(3):487-92. PubMed ID: 12623809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.